Sotera Health (SHC)
Nasdaq Market Open
Sotera Health Company is a specialised provider of services that support the safety of medical devices, pharmaceuticals, food products, and other regulated goods. The company works with manufacturers that need sterilisation, laboratory testing, and technical consulting to meet quality, regulatory, and product safety requirements before items reach healthcare professionals, patients, and consumers.
Sotera Health operates through three main businesses: Sterigenics, Nordion, and Nelson Labs. Sterigenics is the largest contributor to revenue and provides outsourced terminal sterilisation and irradiation services. Its technologies include gamma irradiation, ethylene oxide processing, and electron beam irradiation, each used for different product types, packaging formats, and sterilisation requirements. These services are especially important for medical devices and healthcare products that cannot be sterilised effectively by manufacturers in-house or by conventional methods.
Nordion supplies products and services connected to gamma technologies, including cobalt-60, a radioisotope widely used in industrial sterilisation. Nelson Labs provides microbiological and analytical testing, helping customers assess sterility, biocompatibility, toxicology, packaging integrity, and other quality attributes. Together, the three segments give Sotera Health a broad role across the product safety chain, from testing and validation to commercial sterilisation.
The company serves customers in the United States, Canada, Europe, and other international markets, with the United States representing its largest geographic source of revenue. Sotera Health’s business is shaped by healthcare production volumes, regulatory standards, outsourcing trends, and demand for safe, sterile products. Its services are typically mission-critical because many medical and pharmaceutical products cannot be distributed without validated sterilisation or testing evidence.
Last updated
- Market Cap
- 4.44B
- P/E
- 37.69
- P/FCF
- 45.85
- P/S
- 3.73
- Enterprise Value
- 6.36B
- Sector
- —
- Industry
- —
- Address
- 9100 SOUTH HILLS BLVD, SUITE 300, BROADVIEW HEIGHTS, OH, 44147
Sotera Health Appoints Kenneth D. Krause to the Board of Directors
Sotera Health Announces Secondary Offering of Common Stock
Sotera Health Company Appoints Vincent K. Petrella as Lead Independent Director
Sotera Health to Share Next Chapter of Growth at 2024 Investor Day
Pharmaceutical Sterility Testing Market to Drive Revenue to USD 3.79 Billion by 2032 | CAGR 11.58%
Sotera Health Announces Secondary Offering of Common Stock
Sotera Health Announces Second-Quarter 2024 Earnings Release Date - GlobeNewswire
Establishment Labs (ESTA) Surges 7.4%: Is This an Indication of Further Gains?
Sotera Health Announces Closing of $1.5 Billion Term Loan B and $750 Million Senior Secured Note Financings
Sotera Health Company (SHC) Misses Q1 Earnings and Revenue Estimates
Sotera Health Reports First-Quarter 2024 Results
Sotera Health Company (SHC) Reports Next Week: Wall Street Expects Earnings Growth
Sotera Health Announces First-Quarter 2024 Earnings Release Date
Sotera Health Announces Pricing of Secondary Offering
Sotera Health Announces Secondary Offering of Common Stock
Sotera Health Company (SHC) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Sotera Health Company (SHC) Meets Q4 Earnings Estimates
Sotera Health Reports Fourth-Quarter and Full-Year 2023 Results; Provides 2024 Outlook
Unveiling Sotera Health Company (SHC) Q4 Outlook: Wall Street Estimates for Key Metrics
Teladoc (TDOC) Reports Q4 Loss, Misses Revenue Estimates
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 4.44B
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- 6.36B
- P/E
P/E ratio compares a company's share price to its earnings per share.
- 37.69
- P/B
P/B ratio compares a company's share price to its book value per share.
- 7.13
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 3.73
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- 11.11
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 5.35
- EPS
- 0.41
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 0%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- 45.85
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- 17
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- 96.84M
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- 18.92%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- 3.64%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 3.59
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 2.81
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 2.53
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 1.51
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 3.9M
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 15.57
Income Statement
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Revenue | 280.05M | 303.44M | 311.31M | 294.34M | 254.52M |
| Gross profit | 147.07M | 165.92M | 177.56M | 166.62M | 135.43M |
| Operating income | 75.83M | 170.33M | 111.18M | 88.43M | 26.1M |
| EBITDA | 106.64M | 202.85M | 139.54M | 123.45M | 97.85M |
| Net income | 26.59M | 34.85M | 48.4M | 7.96M | -13.26M |
| Basic EPS | 0.09 | 0.12 | 0.17 | 0.03 | -0.05 |
| Diluted EPS | 0.09 | 0.12 | 0.17 | 0.03 | -0.05 |
Balance Sheet
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Total assets | 3.24B | 3.26B | 3.19B | 3.22B | 3.1B |
| Total liabilities | 2.61B | 2.66B | 2.64B | 2.71B | 2.68B |
| Total equity | 622.51M | 606.04M | 550.47M | 511.28M | 414.09M |
| Cash & equivalents | 314.15M | 344.62M | 299.19M | 332.44M | 304.39M |
| Current assets | 584.17M | 611.58M | 575.98M | 606.34M | 553.3M |
| Current liabilities | 207.8M | 249.58M | 242.4M | 246.32M | 225.99M |
Cash Flow
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Operating cash flow | 29.44M | 103.1M | 71.15M | 57.42M | 55.52M |
| Investing cash flow | -45.13M | -50.7M | -33.34M | -31.23M | -19.88M |
| Financing cash flow | -12.78M | -8.18M | -77.34M | -6.93M | -8.09M |
| Change in cash | -30.51M | 45.43M | -33.25M | 28.19M | 27.22M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | SD — Sotera Health Co | View Filing | |
| edgar index | 4 — Sotera Health Co | View Filing | |
| edgar index | 4 — Sotera Health Co | View Filing | |
| edgar index | 4 — Sotera Health Co | View Filing | |
| edgar index | 4 — Sotera Health Co | View Filing | |
| edgar index | 4 — Sotera Health Co | View Filing | |
| edgar index | 4 — Sotera Health Co | View Filing | |
| edgar index | 4 — Sotera Health Co | View Filing | |
| edgar index | 4 — Sotera Health Co | View Filing | |
| edgar index | 4 — Sotera Health Co | View Filing | |
| edgar index | 3 — Sotera Health Co | View Filing | |
| edgar index | 4 — Sotera Health Co | View Filing | |
| edgar index | 4 — Sotera Health Co | View Filing | |
| form 4 | Form 4 — SHADER ALTON | View Filing | |
| form 4 | Form 4 — SHADER ALTON | View Filing | |
| form 4 | Form 4 — SHADER ALTON | View Filing | |
| edgar index | 8-K — Sotera Health Co | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| form 4 | Form 4 — Wheadon David E. | View Filing | |
| form 4 | Form 4 — Simon, Christopher | View Filing | |
| form 4 | Form 4 — Chen Ruoxi | View Filing | |
| form 4 | Form 4 — PETRELLA VINCENT K | View Filing | |
| form 4 | Form 4 — Neary James | View Filing | |
| form 4 | Form 4 — Flynn Karen | View Filing | |
| form 4 | Form 4 — CUNNINGHAM SEAN LAURENCE | View Filing | |
| form 4 | Form 4 — Krause Kenneth D. | View Filing | |
| form 4 | Form 4 — Kyle Richard G | View Filing | |
| form 4 | Form 4 — Klee Ann R. | View Filing | |
| edgar index | 8-K — Sotera Health Co | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | SCHEDULE 13G — Sotera Health Co | View Filing | |
| edgar index | SCHEDULE 13G/A — Sotera Health Co | View Filing | |
| edgar index | 4 — Sotera Health Co | View Filing | |
| edgar index | 4 — Sotera Health Co | View Filing | |
| edgar index | 4 — Sotera Health Co | View Filing | |
| edgar index | SCHEDULE 13G/A — Sotera Health Co | View Filing | |
| edgar index | 8-K — Sotera Health Co | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| form 4 | Form 4 — GTCR FUND XI/A LP | View Filing | |
| form 4 | Form 4 — GTCR FUND XI/C LP | View Filing | |
| form 4 | Form 4 — GTCR CO-INVEST XI LP | View Filing | |
| form 4 | Form 4 — GTCR INVESTMENT XI LLC | View Filing | |
| form 4 | Form 4 — GTCR PARTNERS XI/A&C LP | View Filing | |
| form 4 | Form 4 — Warburg Pincus XI Partners, L.P. | View Filing | |
| form 4 | Form 4 — Bull Co-Invest L.P. | View Filing | |
| form 4 | Form 4 — Warburg Pincus XI, L.P. | View Filing | |
| form 4 | Form 4 — Warburg Pincus Private Equity XI-B, L.P. | View Filing | |
| form 4 | Form 4 — Warburg Pincus Partners II, L.P. | View Filing | |
| form 4 | Form 4 — Bull Holdco L.P. | View Filing | |
| form 4 | Form 4 — WP XI Partners, L.P. | View Filing | |
| form 4 | Form 4 — Warburg Pincus Private Equity XI, L.P. | View Filing | |
| form 4 | Form 4 — WP Global LLC | View Filing | |
| form 4 | Form 4 — WARBURG PINCUS & CO. | View Filing | |
| form 4 | Form 4 — WARBURG PINCUS LLC | View Filing | |
| form 4 | Form 4 — Warburg Pincus Private Equity XI-C, L.P. | View Filing | |
| form 4 | Form 4 — Warburg Pincus Partners GP LLC | View Filing | |
| form 4 | Form 4 — WARBURG PINCUS & CO. | View Filing | |
| form 4 | Form 4 — Warburg Pincus (Bermuda) Private Equity GP Ltd. | View Filing | |
| form 4 | Form 4 — Warburg Pincus XI-C, LLC | View Filing | |
| form 4 | Form 4 — Warburg Pincus Partners II (Cayman), L.P. | View Filing | |
| form 4 | Form 4 — Warburg Pincus (Cayman) XI, L.P. | View Filing | |
| edgar index | 424B7 — Sotera Health Co | View Filing | |
| edgar index | 424B7 — Sotera Health Co | View Filing | |
| edgar index | DEFA14A — Sotera Health Co | View Filing | |
| edgar index | 8-K — Sotera Health Co | View Filing | |
| edgar index | 10-Q — Sotera Health Co | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | DEF 14A — Sotera Health Co | View Filing | |
| edgar index | DEFA14A — Sotera Health Co | View Filing | |
| edgar index | ARS — Sotera Health Co | View Filing | |
| edgar index | 3 — Sotera Health Co | View Filing | |
| form 3 | Form 3 — Ostrowski Erika | View Filing | |
| form 3 | Form 3 — Ostrowski Erika | View Filing | |
| form 3 | Form 3 — Ostrowski Erika | View Filing | |
| form 3 | Form 3 — Ostrowski Erika | View Filing |